Review
Open access
Aug 2026
The Microbiome in the Development and Treatment of Inflammatory Bowel Disease
Current evidence supports gut microbiota as both a key determinant of IBD pathogenesis and a promising therapeutic target, underscoring the need for more precise and personalized microbiota-directed approaches in IBD management.
Sanzhar Zhetkenev, Roman Konovalov, Azamat Akhmetkaliyev et al.
· Biomedicines · 0 citations